Spiramycin (hexanedioate)

CAT:
804-HY-100593A
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Spiramycin (hexanedioate) - image 1

Spiramycin (hexanedioate)

  • UNSPSC Description:

    Spiramycin hexanedioate (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect. Spiramycin hexanedioate is composed of a 16-member lactone ring, on which three sugars (mycaminose, forosamine, and mycarose) are attached[1][2].
  • Target Antigen:

    Antibiotic; Bacterial; Parasite
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection
  • Assay Protocol:

    https://www.medchemexpress.com/spiramycin-hexanedioate.html
  • Smiles:

    O=C(O)CCCCC(O)=O.O[C@H](C1)[C@H](OC)[C@@H](O[C@H]2[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@](O)(C)C3)[C@@H](C)O2)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@@H]4O[C@H](C)[C@@H](N(C)C)CC4)/C=C/C=C/C[C@@H](C)OC1=O
  • Molecular Weight:

    989.19
  • References & Citations:

    [1]Nguyen HC, et al. Post-PKS tailoring steps of the spiramycin macrolactone ring in Streptomyces ambofaciens. Antimicrob Agents Chemother. 2013 Aug;57(8):3836-42.|[2]Etewa SE, et al. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice. J Parasit Dis. 2018 Mar;42(1):102-113.|[3]Guo HY, et al. Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-Toxoplasma gondii Agents. J Agric Food Chem. 2019 Aug 28;67(34):9630-9642.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    Phase 4
  • CAS Number:

    11034-40-5